Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102154384A reveals efficient recombinant E. coli method yielding >26g/L with >99% ee, offering significant cost and supply chain advantages.
Patent CN107858384A reveals a fusion enzyme method for L-tert-leucine. Offers high purity, thermal stability, and reusable biocatalysts for cost-effective pharmaceutical intermediate manufacturing.
Patent CN119823958B reveals high-yield enzyme route for Clopidogrel intermediate offering cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN112852771A details enzymatic synthesis of chiral amino alcohols using imine reductase, offering high stereoselectivity and mild conditions for pharmaceutical manufacturing.
Novel metal-catalyzed synthesis offers mild conditions and high yields for phenyl pyrrolidine intermediates, ensuring supply chain stability and cost efficiency.
Patent CN110511166B details a green one-pot synthesis using recyclable Amberlyst-15 in water, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN115820584A reveals high-efficiency mutants for L-phenylglycine and L-2-aminobutyric acid synthesis, offering cost reduction and supply reliability.
Novel palladium coordination polymer catalyst enables recyclable carbon-carbon coupling. Reduces contamination and supports scalable pharmaceutical intermediate manufacturing efficiently.
Novel palladium coordination polymer catalyst enables recyclable carbon-carbon coupling. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN117903203A introduces a novel pyridine-based binuclear ligand enhancing enantioselectivity and offering cost reduction in asymmetric catalysis manufacturing for global supply chains.
Patent CN1554646A details a novel chemo-enzymatic route for lactam production. This method offers significant cost reduction in fine chemical manufacturing through high regioselectivity and simplified downstream processing.
Patent CN109369638B details a green, high-yield synthesis of dasatinib intermediates using heteropolyacid catalysis, offering significant cost reduction in API manufacturing.
Patent CN102127003B details a novel organocatalytic route for Tamiflu intermediates, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN107892698B details a solvent-free ruthenium catalyzed selective borylation method offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Patent CN102924489A details a novel one-step synthesis of tri[(S)-leucinol]zinc bichloride. This report analyzes cost reduction and supply chain reliability for chiral catalyst manufacturing.
Novel CrCl3-catalyzed route for (S)-phenylglycinol hydrochloride. Enhances purity and reduces costs for pharmaceutical intermediate manufacturing.
Patent CN102850383A details a novel chiral zinc-nitrogen complex enabling efficient asymmetric catalysis for fine chemical manufacturing and supply chain optimization.
Patent CN111349048A reveals a mild, cost-effective synthesis of 2-arylbenzimidazoles using earth-abundant metal catalysts, offering significant supply chain advantages.
Patent CN111825612B reveals a cost-effective four-step route for high-purity quinoxaline intermediates, offering significant supply chain advantages for API manufacturers.
Novel DES-based route for gamma-carbonyl sulfones offers high yield and green processing for pharmaceutical intermediates supply chains ensuring reliability and cost efficiency.